One study reported that the roles of CLCA2 in breast cancer include inhibiting proliferation, promoting apoptosis or senescence, and maintaining the cytotoxic response of cancer cells in response to doxorubicin treatment [21]. The gene discussed is CLCA2; the disease is breast carcinoma.